2021
DOI: 10.1111/all.14792
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic profile of extracellular vesicles in anaphylaxis and their role in vascular permeability

Abstract: To the Editor, Anaphylaxis is a life-threatening allergic disorder 1 for which there is a need for improved diagnostic techniques and a deeper understanding of the molecular mechanisms involved. 2 Extracellular vesicles (EVs) play a key role in cellular communication, offering new possibilities with which to analyze patient particularities. 3 We hypothesized that anaphylaxis-derived EVs could provide potential markers of anaphylaxis due to their participation in the underlying molecular mechanisms. Vesicles we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 6 publications
0
10
0
Order By: Relevance
“…Due to a recent study from our group that demonstrated an active participation of extracellular vesicles interacting with ECs in anaphylaxis, 16 an in vitro serum‐EC system was carried out to evaluate the functional role of miR‐21‐3p and miR‐487b‐3p in this event. In order to do so, intracellular levels of both miRNAs were measured after incubation with anaphylactic conditions: cocktail of mediators and serum from patients (acute and basal phases).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Due to a recent study from our group that demonstrated an active participation of extracellular vesicles interacting with ECs in anaphylaxis, 16 an in vitro serum‐EC system was carried out to evaluate the functional role of miR‐21‐3p and miR‐487b‐3p in this event. In order to do so, intracellular levels of both miRNAs were measured after incubation with anaphylactic conditions: cocktail of mediators and serum from patients (acute and basal phases).…”
Section: Discussionmentioning
confidence: 99%
“…Human dermal microvascular ECs (HMVEC‐D) were acquired from Lonza CC‐2543 and maintained in EGM™‐2MV BulletKit™ as previously described. 16 , 17 EC monolayers were incubated for 2 hours with: EGM‐2 medium (negative control), a cocktail of anaphylaxis mediators, or serum samples (acute and basal) from 5 patients. Mediators included in the cocktail were histamine, platelet‐activating factor (PAF), and thrombin (all from Sigma).…”
Section: Methodsmentioning
confidence: 99%
“…Two studies assessed the proteome change in anaphylaxis in patients ( 24 , 25 ). In the first study, the authors aimed to pinpoint specific biomarkers in plasma for predicting individuals with mastocytosis at a heightened risk of experiencing anaphylaxis.…”
Section: Resultsmentioning
confidence: 99%
“…The fibroblast growth factor-inducible 14 (Fn14) receptor, the signal transducer and activator of transcription 3 (STAT3), the peroxisome proliferator-activated receptor (PPAR β/δ), and MALT1 protease activity have been proposed as therapeutic strategies in allergy and anaphylaxis ( 84 , 175 , 183 185 ). In addition, recently, a challenge study has demonstrated the capacity of EVs purified from plasma of anaphylactic patients to interact with ECs, eliciting vascular permeability and thereby suggesting that cellular communication between microenvironments may also be established in anaphylaxis ( 186 ).…”
Section: Cardiovascular Pathophysiology Of Anaphylaxismentioning
confidence: 99%